Buprenorphine Rapid Test
Product Description
The Buprenorphine Rapid Test is a qualitative immunoassay designed for the rapid detection of buprenorphine in human urine. This point-of-care test provides a convenient and efficient method for screening individuals for the presence of buprenorphine, a commonly prescribed opioid partial agonist used in medication-assisted treatment (MAT) for opioid use disorder. The test is easy to perform and delivers results quickly, aiding healthcare professionals in monitoring patient compliance and assessing the effectiveness of their treatment regimen. The test can also be used in clinical settings to detect potential misuse or abuse of buprenorphine.
Features
-
Rapid results in under 10 minutes
-
Easy-to-use, single-step procedure
-
Visually interpretable results (positive/negative)
Specifications
| Parameter | Specification |
|---|---|
| Detection Target | Buprenorphine |
| Sample Type | Urine |
| Methodology | Immunochromatography |
| Detection Range | Qualitative (Positive/Negative) |
| Reaction Time | 5-10 minutes |
| Storage Conditions | 2-30°C |
| Shelf Life | 18 months |
Product Advantages
Early Screening Tool
Helps quickly identify infected individuals, implement timely isolation measures, and control the spread of the epidemic.
Suitable for Multiple Scenarios
Suitable for various scenarios such as home self-testing, corporate screening, schools, and clinics.
Reliable Quality
Strict quality control system ensures stable and reliable product performance.
Instructions for Use
- Read the instructions carefully.
- Prepare sample collection tools and the test kit.
- Collect the sample according to the instructions.
- Add the sample to the test cassette.
- Wait 15 minutes to read the results.
Certification Information
- CE Certified
- ISO13485
Interested in Buprenorphine Rapid Test?
Contact us for pricing, bulk orders, or any questions you may have.
